Evidence map›Paper›PMID 24641692›Full record

ArticleBritish journal of pharmacology2014

Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.

Kouichi Yamamoto, Keiko Asano, Ayana Tasaka, Yuko Ogura, Seikou Kim, Yui Ito, Atsushi Yamatodani

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Evaluating proxies for motion sickness in rodent.IBRO neuroscience reports · 2023
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Prevention of cisplatin-induced nausea and vomiting by seabuckthorn (Iranian journal of basic medical sciences · 2021
    Article
  10. Involvement of 5-Serotonin and SubstanceFrontiers in pharmacology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kouichi YamamotoDepartment of Medical Science and Technology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Keiko Asano
Ayana Tasaka
Yuko Ogura
Seikou Kim
Yui Ito
Atsushi Yamatodani
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAlthough substance P (SP) and neurokinin NK1 receptors have been reported to be involved in cisplatin-induced acute and delayed emesis, their precise roles remain unclear. Pica, the consumption of non-nutrient materials such as kaolin in rats, can be used as a model of nausea in humans. We investigated the time-dependent changes in cisplatin-induced pica and the involvement of SP and NK1 receptors in this behaviour. EXPERIMENTAL APPROACH: Rats were administered cisplatin with or without a daily injection of a 5-HT3 receptor antagonist (granisetron) or an NK1 receptor antagonist (aprepitant), and kaolin intake was then monitored for 5 days. The effects of granisetron on the cisplatin-induced expression of preprotachykinin-A (PPT-A) mRNA, which encodes mainly for SP, and on SP release in the medulla, measured by in vivo brain microdialysis, were also investigated. KEY

resultsCisplatin induced pica within 8 h of its administration that continued for 5 days. Granisetron inhibited the acute phase (day 1), but not the delayed phase (days 2-5), of pica, whereas aprepitant abolished both phases. Within 24 h of the injection of cisplatin, PPT-A mRNA expression and SP release in the medulla were significantly increased; these findings lasted during the observation period and were inhibited by granisetron for up to 24 h. CONCLUSIONS AND IMPLICATIONS: The profiles of cisplatin-induced pica in rats are similar to clinical findings for cisplatin-induced emesis in humans, and we showed that SP production in the medulla and activation of NK1 receptors are involved in this cisplatin-induced pica.

Indexed as

AnimalsAntiemeticsAntineoplastic AgentsAprepitantCisplatinEatingGranisetronKaolinMaleMedulla OblongataMorpholinesNauseaNeurokinin-1 Receptor AntagonistsPicaProtein PrecursorsRats, WistarAntiemeticsAntineoplastic AgentsAprepitantCisplatinGranisetronKaolinMorpholinesNeurokinin-1 Receptor AntagonistspreprotachykininProtein PrecursorsReceptors, Neurokinin-1Receptors, Serotonin, 5-HT3RNA, MessengerSerotonin AntagonistsSubstance PTachykinins5-HT3 receptoracute emesisbrain microdialysiscisplatindelayed emesismedullaneurokinin NK1 receptorpicapreprotachykinin-Asubstance P

Identifiers

PMID24641692
PMCPMC4243862
OpenAlexW1669275624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.